Saxon Interests »

Crispr Therapeutics shares owned by Saxon Interests

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Saxon Interests from 13F filings

Historical chart of Saxon Interests investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Saxon Interests consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Saxon Interests

Quarter filed Position value Share count Share price at filing
2026-03-31 $694k 15k 47.57

More positions owned by Saxon Interests

Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Etf Ser Solutions Distillate Us (DSTL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Amazon (AMZN)
Pimco Etf Tr Inter Mun Bd Act (MUNI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Doubleline Etf Trust Commercial Real (DCRE)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Ishares Tr Msci Intl Vlu Ft (IVLU)

View all positions for Saxon Interests

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Susquehanna International
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Two Sigma Investments

View all funds holding Crispr Therapeutics